Instrument-independent chemometric models for rapid, calibration-free NPS isomer differentiation from mass spectral GC-MS data.

Chemometric analysis of mass spectral data for the purpose of differentiating positional isomers of novel psychoactive substances has seen a substantial increase in popularity in recent years. However, the process of generating a large and robust dataset for chemometric isomer identification is time consuming and impractical for forensic laboratories. To begin to address this problem, three sets of ortho/meta/para positional ring isomers (fluoroamphetamine (FA), fluoromethamphetamine (FMA), and methylmethcathinone (MMC)) were analyzed using multiple GC-MS instruments at three distinct laboratories. A diverse assortment of instrument manufacturers, model types, and parameters was utilized in order to incorporate substantial instrumental variation. The dataset was randomly split into 70% training and 30% validation sets, stratified by instrument. Following an approach based on Design of Experiments, the validation set was used to optimize the preprocessing steps performed prior to Linear Discriminant Analysis. Using the optimized model, a minimum m/z fragment threshold was determined to allow analysts to assess whether an unknown spectrum is of sufficient abundance and quality to be compared to the model. To assess the robustness of the models, a test set was developed utilizing two instruments from a fourth laboratory that was not involved in the generation of the primary dataset in addition to spectra from widely used mass spectral libraries. Of the spectra that reached the threshold, the classification accuracy was 100% for all three isomer types. Only two of the test and validation spectra that did not reach the threshold were misclassified. The results indicate that forensic illicit drug experts world-wide can use these models for robust NPS isomer identification on the basis of preprocessed mass spectral data without the need for acquiring reference drug standards and creating instrument specific GC-MS reference datasets. The continued robustness of the models could be ensured through international collaboration to collect data that captures all potential GC-MS instrumental variation encountered in forensic illicit drug analysis laboratories. This would allow every forensic institute to confidently assign isomeric structures without the need for additional chemical analysis.